Experimental drug development approach points to better targeted therapies for treatment-resistant leukemia
New research shows why some drugs in clinical trials for treating a form of acute myeloid leukemia (AML) often fail and demonstrates a way to restore their effectiveness.
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/09/210927172917.htm
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/09/210927172917.htm
Experimental drug development approach points to better targeted therapies for treatment-resistant leukemia
![Experimental drug development approach points to better targeted therapies for treatment-resistant leukemia]()
Reviewed by cmakigo
on
September 28, 2021
Rating:
No comments:
Post a Comment